ACM
PMVP icon

Asymmetry Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Asymmetry Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$2.26M Sell
97,680
-3,202
-3% -$77.4K 1.2% 22
2021
Q3 		$3.01M Sell
100,882
-894
-0.9% -$28.5K 1.81% 22
2021
Q2 		$3.48M Sell
101,776
-16,352
-14% -$546K 2.39% 16
2021
Q1 		$3.88M Buy
118,128
+21,533
+22% +$849K 2.01% 21
2020
Q4 		$5.94M Buy
96,595
+71,703
+288% +$2.81M 2.71% 15
2020
Q3 		$884K Buy
+24,892
New +$916K 0.57% 32

Other funds holding PMVP

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return